Drug Warning: Ritalin
Generic name: methylphenidate hydrochloride (class of ADHD drugs known as methylphenidates)
Manufactured and marketed by: Novartis Pharmaceuticals
Purpose: Prescribed for individuals who suffer from attention deficit hyperactivity disorder, which is commonly referred to as ADHD or ADD.
Side Effects Reported
- As reported in various media outlets, on February 9, 2006 the Drug Safety and Risk Management advisory committee urged the FDA to change the labeling of ADHD drugs and add stern warnings about the potential heart risks associated with the drugs.
- These heart side effects may include heart attacks, stroke, arrhythmia, and even sudden death.
Industry Report
The noted advisory panel above acted after a study found an increased risk of heart attacks and strokes in adults taking ADHD drugs. The ADHD drugs have been linked to approximately 54 cases of serious cardiovascular side effects and as many as 25 deaths between 1999 and 2003. Nineteen of the 25 deaths were of children. The advisory panel also voted unanimously to recommend that the FDA require medication guides be given to ADHD patients who take these drugs.
Seeger Weiss is not currently pursuing lawsuits on this drug, but its drug warnings will remain on our radar.
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
